Chemotherapy-Associated Vascular Endothelial Injury and Protection

Expand
  • (1Department of Cardiovascular Medicine, Second Affiliated Hospital of Zhengzhou University; 2Department of Biochemistry and Biophysics, Peking University Health Science Center, Beijing 100191,China; 3Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou 450003,China)
△ sahjlg@zzu.edu.cn

Received date: 2023-03-16

  Revised date: 2023-04-18

  Accepted date: 2023-04-21

  Online published: 2024-03-04

Abstract

With the rapid development of tumor chemotherapy, the overall survival of tumor patients has been continuously prolonged. However, the cardiovascular toxic side effects caused by chemotherapy seriously limit the effectiveness of tumor treatment, and have become a high-risk factor affecting the quality of life and survival rate of patients. Among them, chemotherapy-related vascular endothelial injury can disrupt vascular homeostasis, which serves as the pathological basis of cardiovascular toxic side effects such as acute vascular events (vasospasm, acute myocardial infarction, stroke, etc.), atherosclerosis, hypertension, and aneurysms. Exploring the mechanisms and protective strategies of chemotherapy-related vascular endothelial injury is of great clinical significance. This review aims to summarize the latest progress in the mechanisms of chemotherapy-associated vascular endothelial injury and related protective strategies.

Cite this article

SHEN Jia1, JIAN Dong-Dong2, TANG Hao3, JIAN Li-Guo1, △ . Chemotherapy-Associated Vascular Endothelial Injury and Protection[J]. Progress in Physiological Sciences, 2024 , 55(1) : 59 -65 . DOI: 10.20059/j.cnki.pps.2023.08.1011

Options
Outlines

/